Dimensional Fund Advisors LP Has $361.70 Million Stock Holdings in Colgate-Palmolive (NYSE:CL)

Dimensional Fund Advisors LP increased its position in Colgate-Palmolive (NYSE:CL - Free Report) by 5.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 3,978,685 shares of the company's stock after purchasing an additional 220,326 shares during the period. Dimensional Fund Advisors LP owned about 0.49% of Colgate-Palmolive worth $361,700,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Barclays PLC raised its holdings in shares of Colgate-Palmolive by 38.7% during the third quarter. Barclays PLC now owns 7,644,189 shares of the company's stock worth $793,542,000 after acquiring an additional 2,132,747 shares in the last quarter. M&T Bank Corp increased its position in Colgate-Palmolive by 8.2% in the 3rd quarter. M&T Bank Corp now owns 288,050 shares of the company's stock worth $29,903,000 after purchasing an additional 21,862 shares during the last quarter. Te Ahumairangi Investment Management Ltd lifted its holdings in shares of Colgate-Palmolive by 2.5% during the 3rd quarter. Te Ahumairangi Investment Management Ltd now owns 43,957 shares of the company's stock valued at $4,537,000 after buying an additional 1,060 shares during the last quarter. Chelsea Counsel Co. grew its stake in shares of Colgate-Palmolive by 10.0% in the 3rd quarter. Chelsea Counsel Co. now owns 5,500 shares of the company's stock valued at $571,000 after buying an additional 500 shares in the last quarter. Finally, Fulcrum Equity Management increased its holdings in Colgate-Palmolive by 3.0% in the third quarter. Fulcrum Equity Management now owns 5,280 shares of the company's stock worth $548,000 after buying an additional 153 shares during the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on the stock. Raymond James reiterated an "outperform" rating and issued a $105.00 target price (down from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. StockNews.com cut shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Wednesday, April 16th. UBS Group raised their target price on Colgate-Palmolive from $105.00 to $109.00 and gave the company a "buy" rating in a report on Thursday, April 17th. TD Cowen decreased their price target on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating for the company in a research note on Wednesday, January 8th. Finally, JPMorgan Chase & Co. cut their price objective on Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating on the stock in a research note on Friday, April 11th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat, Colgate-Palmolive currently has a consensus rating of "Hold" and a consensus target price of $102.17.

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock traded down $1.23 during trading on Thursday, hitting $92.66. 11,290,916 shares of the company's stock traded hands, compared to its average volume of 5,447,906. Colgate-Palmolive has a twelve month low of $85.32 and a twelve month high of $109.30. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. The company has a market cap of $75.16 billion, a PE ratio of 26.32, a PEG ratio of 4.20 and a beta of 0.40. The firm's fifty day moving average price is $91.78 and its 200 day moving average price is $92.31.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the prior year, the firm posted $0.87 earnings per share. Analysts forecast that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Thursday, April 17th will be given a dividend of $0.52 per share. The ex-dividend date of this dividend is Thursday, April 17th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.24%. This is a boost from Colgate-Palmolive's previous quarterly dividend of $0.50. Colgate-Palmolive's dividend payout ratio (DPR) is 59.09%.

Colgate-Palmolive declared that its Board of Directors has approved a stock repurchase program on Thursday, March 20th that allows the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization allows the company to repurchase up to 6.8% of its shares through open market purchases. Shares repurchase programs are often a sign that the company's board of directors believes its shares are undervalued.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.